Get the Stockscreener App
3.16
7.51%
0.23
After Hours:
3.13
-0.03
-0.95%
Annexon Inc stock is traded at $3.16, with a volume of 3.66M.
It is up +7.51% in the last 24 hours and up +3.28% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$2.93
Open:
$2.93
24h Volume:
3.66M
Relative Volume:
2.04
Market Cap:
$347.24M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.7853
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
-1.87%
1M Performance:
+3.28%
6M Performance:
+69.35%
1Y Performance:
-56.97%
1-Day Range:
$2.89
$3.235
1-Week Range:
$2.89
$3.60
52-Week Range:
$1.285
$7.625
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650)-822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
3.16 | 321.97M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Will Annexon Inc. stock deliver better than expected guidance2025 Trading Recap & Real-Time Chart Breakout Alerts - newser.com
Real time scanner hits for Annexon Inc. explainedWeekly Risk Report & Fast Exit Strategy with Risk Control - newser.com
How currency fluctuations impact Annexon Inc. stockQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
Can momentum traders help lift Annexon Inc.2025 Stock Rankings & Consistent Profit Alerts - newser.com
Why Annexon Inc. stock remains undervaluedWeekly Investment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Annexon Inc. still worth holding after the dipQuarterly Profit Report & Daily Market Momentum Tracking - newser.com
Is Annexon Inc. stock a buy for dividend growthMarket Volume Summary & Consistent Return Investment Signals - newser.com
How geopolitical tensions affect Annexon Inc. stock2025 Big Picture & Entry Point Confirmation Signals - newser.com
Annexon Inc. stock daily chart insights2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
Is it too late to sell Annexon Inc.Trade Analysis Summary & Weekly Market Pulse Updates - newser.com
Can Annexon Inc. stock surprise with earnings upsideQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
Will Annexon Inc. stock rally after Fed decisionsMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Why Annexon Inc. stock is favored by top institutionsPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Is Annexon Inc. stock a safe investment in uncertain markets2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Is Annexon Inc. meeting your algorithmic filter criteria2025 Market Sentiment & Daily Profit Focused Screening - newser.com
Is Annexon Inc. reversing from oversold territoryMarket Sentiment Review & Growth Focused Stock Pick Reports - newser.com
Is Annexon Inc. stock a defensive play in 2025Market Volume Summary & Short-Term Trading Opportunity Alerts - newser.com
Annexon Inc. stock momentum explainedMarket Trend Summary & Reliable Entry Point Trade Alerts - newser.com
Key metrics from Annexon Inc.’s quarterly dataForecast Cut & AI Driven Stock Movement Reports - newser.com
Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Should you hold or exit Annexon Inc. nowJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com
Chart overlay techniques for tracking Annexon Inc.Gold Moves & Risk Controlled Stock Alerts - newser.com
Annexon Inc. recovery potential after sell offAnalyst Downgrade & Pattern Based Trade Signal System - newser.com
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Annexon Inc Stock (ANNX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Carson William H. | Director |
Sep 02 '25 |
Buy |
2.09 |
4,115 |
8,600 |
37,945 |
| Carson William H. | Director |
Jul 30 '25 |
Buy |
2.43 |
4,115 |
9,999 |
33,830 |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER |
Jul 14 '25 |
Sale |
2.58 |
1,116 |
2,879 |
105,084 |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER |
Jul 14 '25 |
Sale |
2.58 |
1,117 |
2,882 |
121,616 |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER |
Jul 14 '25 |
Sale |
2.61 |
853 |
2,226 |
130,689 |
1.68%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):